Betty Jean Bardella, MD in Jamestown, PA - Family Medicine

Betty Jean Bardella, MD is a Family Medicine physician based in Jamestown, Pennsylvania. Betty Jean Bardella is licensed to practice in Pennsylvania (license number MD418701) and her current practice location is 402 Jackson St, Jamestown, Pennsylvania. She can be reached at her office (for appointments etc.) via phone at (724) 932-2299.

NPI number for Betty Jean Bardella is 1083697866 and her current mailing address is 100 Shenango Ave, Sharon, Pennsylvania. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1083697866.

Contact Information

	Betty Jean Bardella, MD
	402 Jackson St, Jamestown, PA 16134-9186
	(724) 932-2299
	(724) 932-2242

Physician's Profile

Full Name	Betty Jean Bardella
Gender	Female
Speciality	Family Medicine
Location	402 Jackson St, Jamestown, Pennsylvania
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1083697866
Provider Enumeration Date: 11/25/2005
Last Update Date: 09/09/2011

Medical Identifiers

Medical identifiers for Betty Jean Bardella such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1083697866	NPI	-	NPPES
0018833510003	Medicaid	PA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	MD418701 (Pennsylvania)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Betty Jean Bardella is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Betty Jean Bardella, MD 100 Shenango Ave, Sharon, PA 16146-1503 Ph: (724) 704-7386	Betty Jean Bardella, MD 402 Jackson St, Jamestown, PA 16134-9186 Ph: (724) 932-2299

News Archive

Alexza Pharmaceuticals announces development and commercialization collaboration with Biovail Laboratories International

Alexza Pharmaceuticals, Inc. announced today that it has established a collaboration with Biovail Laboratories International SRL, a subsidiary of Biovail Corporation, to develop and commercialize AZ-004 (Staccato® loxapine) in the U.S. and Canada. AZ-004 is Alexza's lead program, based on the company's proprietary technology, the Staccato system. Alexza submitted its New Drug Application (NDA) for Staccato loxapine in December 2009. Alexza is seeking regulatory approval to market AZ-004, an inhalation product candidate developed for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder.

High levels of exercise from young age can benefit patients with cerebral palsy

For highly trained Paralympic athletes with cerebral palsy (CP), bone mineral density and other measures of body composition are similar to those of able-bodied adults of similar age, reports a study in the American Journal of Physical Medicine & Rehabilitation, the official journal of the Association of Academic Physiatrists.

World's poor at huge risk from bird flu

ActionAid International, one of the UK's charity largest development charities which works with over five million of the world's poorest people, has warned that when it comes to the fight against bird flu, in the developing world, making plans is not enough.

Alternative sunitinib treatment schedules for mRCC may be worth the switch

Some patients with metastatic renal cell carcinoma who are switched from a traditional sunitinib treatment schedule to an alternative schedule fare better on survival measures and suffer fewer adverse events, a Japanese study has found.

Betty Jean Bardella, MD - Family Medicine in Jamestown, PA